March 21, 2025

Amended Trial: David Sher Gives an Update on the EA3211 Trial for Patients with Metastatic Squamous Cell Carcinoma of the Head and Neck

The changes significantly broaden eligibility and clarify key details in this phase 3 trial exploring whether adding radiation therapy to standard immunotherapy will improve survival in patients with stable disease after initial treatment